Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation
CAO Xuefen1,2, LENG Yufang2,1, HAN Xiaoxia1, HOU Xiaoyu1, LYU Xingjiao1, Janvier NIBARUTA1
1The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu, China; 2Department of Anesthesiology, the First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.